ZNF621 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.857800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.456600E-01
Normal-vs-Stage2
6.946500E-02
Normal-vs-Stage3
1.331990E-02
Normal-vs-Stage4
6.591600E-01
Stage1-vs-Stage2
8.917600E-01
Stage1-vs-Stage3
2.718200E-02
Stage1-vs-Stage4
2.031200E-01
Stage2-vs-Stage3
3.297600E-02
Stage2-vs-Stage4
1.429020E-01
Stage3-vs-Stage4
5.239900E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.453500E-02
Normal-vs-AfricanAmerican
1.531180E-01
Normal-vs-Asian
7.578000E-02
Caucasian-vs-AfricanAmerican
9.282800E-01
Caucasian-vs-Asian
3.607600E-01
AfricanAmerican-vs-Asian
5.371000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.212200E-02
Normal-vs-Female
7.891600E-02
Male-vs-Female
2.436800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.078600E-01
Normal-vs-Age(41-60Yrs)
1.317430E-01
Normal-vs-Age(61-80Yrs)
5.409900E-02
Normal-vs-Age(81-100Yrs)
1.282260E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.139400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.627800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.223400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.499450E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.080300E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.458010E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.142300E-02
Normal-vs-Daily Drinker
2.815800E-02
Normal-vs-Weekly Drinker
2.257600E-01
Normal-vs-Occasional Drinker
7.250100E-02
Normal-vs-Social Drinker
1.994010E-01
Non Drinker-vs-Daily Drinker
2.819800E-01
Non Drinker-vs-Weekly Drinker
5.181000E-01
Non Drinker-vs-Occasional Drinker
9.103800E-01
Non Drinker-vs-Social Drinker
2.904400E-01
Daily Drinker-vs-Weekly Drinker
1.521970E-01
Daily Drinker-vs-Occasional Drinker
2.727800E-01
Daily Drinker-vs-Social Drinker
5.715900E-02
Weekly Drinker-vs-Occasional Drinker
6.067800E-01
Weekly Drinker-vs-Social Drinker
7.780800E-01
Occasional Drinker-vs-Social Drinker
3.599000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.787950E-01
Normal-vs-Grade 2
3.237700E-02
Normal-vs-Grade 3
3.209900E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.753800E-02
Grade 1-vs-Grade 3
6.828200E-02
Grade 1-vs-Grade 4
1.787950E-01
Grade 2-vs-Grade 3
8.356200E-01
Grade 2-vs-Grade 4
3.237700E-02
Grade 3-vs-Grade 4
3.209900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.038300E-02
Normal-vs-NonDiabetic
6.177700E-02
Diabetic-vs-NonDiabetic
1.583770E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.310200E-01
Normal-vs-NoPancreatitis
3.350400E-02
Pancreatitis-vs-NoPancreatitis
2.711200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.082300E-02
Normal-vs-N1
7.189700E-02
N0-vs-N1
6.261400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.311430E-01
Normal-vs-TP53-NonMutant
2.838600E-01
TP53-Mutant-vs-TP53-NonMutant
6.802000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
